Immunoregulation of Cellular Life Span
- 1 December 2005
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1057 (1), 85-111
- https://doi.org/10.1196/annals.1356.005
Abstract
Our current studies focus on the molecular changes induced by aging. During aging, changes in proteins occur that alter their function and render them immunogenic. These "neoantigens" are recognized by physiologic autoantibodies. Physiologic autoantibodies and their corresponding antigens offer therapeutic strategies for disease intervention through the innate immune response. Early studies done in the 1970s showed humans and animals to have physiologic antibodies that bind to a neoantigen called senescent cell antigen (SCA), which appears on senescent and damaged cells and initiates their removal by macrophages. These studies led to the discovery that oxidation can generate a new antigen in situ. Oxidation accelerated aging of red cells, generated SCA and IgG binding, and triggered removal of red cells by macrophages. Since then, a number of laboratories have found that oxidation can generate other neoantigens. For example, oxidized LDL (OxLDL) induces antibodies that can modify the natural progression of atherosclerosis. Apoptotic cells express oxidatively modified moieties on their surfaces that are involved in macrophage recognition and phagocytosis. Physiologic autoantibodies were used to isolate SCA from brain tissue. HPLC and fast atom bombardment ionization mass spectrometry (FAB-MS) of the isolated antigen suggested that the aging antigen is a subset of band 3, a family of proteins also called anion exchange proteins (AE1-3). FAB-MS results indicate that residues matching all three band 3 isoforms (AE1, AE2, and AE3) are detected in aging antigen fractions. Among the fragments identified with FAB-MS was a sequence corresponding to an aging epitope, human band 3 sequence LFKPPKYHPDVPYVKR, residue 812-830 in AE1; HHPDVTYVK, residue 1144-1152 in AE2; or HHPEQPYVTK, residue 1135-1144 in AE3. A residue that is close to that region was identified in mouse AE1 ASGPGAAAQIQEVK, residue 762-775. The potential for altering the natural progression of diseases using select peptide-defined epitopes within or overlapping the aging antigenic site (547-553 and 824-829) is discussed using the innate immune response to band 3 in malaria as an example.Keywords
This publication has 81 references indexed in Scilit:
- Splenic but not thymic autoreactive T cells from New Zealand Black mice respond to a dominant erythrocyte Band 3 peptideImmunology, 1999
- Brain and Erythrocyte Anion Transporter Protein, Band 3, as a Marker for Alzheimer’s Disease: Structural Changes Detected by Electron Microscopy, Phosphorylation, and AntibodiesGerontology, 1997
- Autoreactive T cell specificity in autoimmune hemolytic anemia of the NZB mouseEuropean Journal of Immunology, 1996
- Monoclonal antibodies that react with human band 3 residues 542?555 recognize different conformations of this protein in uninfected andPlasmodium falciparum infected erythrocytesMolecular and Cellular Biochemistry, 1995
- Altered properties of erythrocytes in the agedAmerican Journal of Hematology, 1993
- Molecular mapping of human band 3 aging antigenic sites and active amino acids using synthetic peptidesProtein Journal, 1992
- Naturally occurring anti-band 3 autoantibodies recognize a high molecular weight protein on the surface of plasmodium falciparum infected erythrocytesBiochemical and Biophysical Research Communications, 1989
- A 115-kD Polypeptide Immunologically Eelated to Erythrocyte Band 3 Is Present in Golgi MembranesScience, 1988
- Band 3 and ankyrin homologues are present in eye lens: Evidence for all major erythrocyte membrane components in same non-erythroid cellBiochemical and Biophysical Research Communications, 1987
- One-sided continuous dependence of maximal solutionsJournal of Differential Equations, 1981